When a Med Spa Scope Problem Becomes a Federal Case: What the Texas APRN Review Tells Florida Clinics

A state nursing board panel recently walked through how Texas polices APRN-run med spas. On its face this is a licensing story. For anyone who owns or staffs one of these clinics, it is also a preview of how a routine scope problem turns into a federal investigation.

Key Takeaways

• A state board investigation produces the exact records federal agents use to build a health care fraud case under 18 U.S.C. § 1347.
• Med spa exposure most often runs through 18 U.S.C. §§ 1347 and 1349, the Anti-Kickback Statute at 42 U.S.C. § 1320a-7b, and unapproved-drug charges under 21 U.S.C. §§ 331 and 333.
• Health care fraud carries up to 10 years per count, with parallel civil False Claims Act liability under 31 U.S.C. § 3729.
• Pre-indictment defense work is where med spa cases are won or lost, not at sentencing.
• The Southern District of Florida is one of the most aggressive federal med spa and health care enforcement zones in the country.

The disciplinary examples from the Texas NCSBN review read like a federal prosecution checklist — IV infusions without proper exams, unlicensed injectors, missing records. Each is a licensing violation. Each is also a fact pattern federal prosecutors recognize.

What the Texas Review Actually Covered

On April 29, 2026, two Texas Board of Nursing presenters walked an NCSBN roundtable through how their state regulates APRN-run med spas. They covered scope of practice, physician delegation, elective IV therapy, the law that followed a patient death, and real disciplinary cases. The session described a market that has exploded since the FDA approved Botox for cosmetic use in 2002 — now a $17 billion industry with more than 10,000 med spas nationwide.

The disciplinary examples are the part worth reading twice. The board described IV infusions given without a good-faith exam, without patient-specific orders, and without adequate supervision. It described cosmetic procedures ordered with no real assessment, diagnosis, or written treatment plan. It described an unlicensed injector, incomplete records, and patient photos posted online without consent.

Each of those is a licensing violation in Texas. Each is also a fact pattern federal prosecutors recognize.

The Texas board described IV infusions given without a good-faith exam, procedures with no written treatment plan, and an unlicensed injector. These are licensing violations — and federal prosecution fact patterns.

Why a Licensing File Becomes a Federal File

State board discipline and federal prosecution are not separate worlds. They run on the same evidence. A board investigation produces sworn statements, patient records, billing data, and a documented finding that a provider operated outside their authority. That record does not disappear when the board closes its file. It becomes a roadmap.

Federal agencies pull on these threads constantly. The combination that draws them is familiar: injectables or IV therapy delivered without proper medical oversight, drugs sourced outside the legitimate supply chain, telehealth prescriptions written across state lines, and claims submitted to a federal payer. When a clinic bills Medicare, Medicaid, or TRICARE for services that were never properly supervised or were medically unnecessary, the case stops being about a license and becomes a health care fraud matter.

South Florida sees this pattern more than almost anywhere. The Southern District of Florida is one of the most aggressive federal health care fraud enforcement zones in the country, and med spas, IV clinics, and telehealth platforms are squarely in its sights. Florida clinics that assume a scope question is only a state matter are reading the situation wrong.

The Federal Statutes in Play

Once a med spa matter goes federal, the exposure changes by an order of magnitude. The statutes that show up most often:

Health care fraud under 18 U.S.C. § 1347 carries up to 10 years per count, and up to 20 if the conduct results in serious bodily injury.

Conspiracy under 18 U.S.C. § 1349 lets the government charge everyone connected to the scheme at the same exposure level as the underlying offense.

The Anti-Kickback Statute, 42 U.S.C. § 1320a-7b, criminalizes paying or receiving anything of value for referrals tied to federal health care programs. Marketing arrangements and physician medical-director fees are common pressure points.

Misbranded and unapproved drug charges under 21 U.S.C. §§ 331 and 333 reach clinics using peptides, compounded GLP-1 products, or injectables obtained outside FDA-approved channels.

Wire fraud under 18 U.S.C. § 1343 sweeps in electronic billing and online marketing.

The civil False Claims Act, 31 U.S.C. § 3729, runs in parallel and imposes treble damages on top of any criminal case.

FDA, HHS-OIG, DEA, and FBI agents share information and pull on the same threads. A state board file, a payer audit, and an FDA supply-chain inquiry are not separate events — they are three entry points to the same federal investigation.

The Mistakes That Make These Cases Worse

Most of the damage in a med spa investigation happens before charges are ever filed, and usually because of decisions the owner made without a lawyer.

Talking to investigators without counsel is the most common. Agents from the FDA, HHS-OIG, DEA, or FBI are trained to build cases through interviews, and a med spa owner explaining their protocols rarely helps themselves.

Producing records in response to a grand jury subpoena without a strategy is next. Handing over a full patient and billing file with no privilege review and no narrative often gives the government the structure of its own case.

The third is assuming silence means safety. A clinic can be under federal investigation for a year before anyone hears the word indictment. By the time a target letter arrives, the key decisions have often already been made.

What Early Defense Actually Accomplishes

The work that matters in these cases is pre-indictment work. While you are still in the investigation stage, the charging decision is not final, and that is the window where a federal criminal defense attorney can change the outcome.

Early intervention lets counsel get ahead of the narrative. That can mean retaining a regulatory expert to document that protocols complied with state delegation rules, separating a good-faith compliance gap from intentional fraud, or showing that the drugs in question came from a legitimate source. It can mean managing the document production so the government sees context, not just raw data. In the right case it means opening a dialogue with the prosecutor before a target letter ever issues.

The decision between cooperating and fighting should be made with full information about exposure, not in a panic after agents show up. If charges do proceed, the same early work shapes sentencing. Loss amount drives the federal guideline range in health care cases, and the distance between the government's loss theory and a defensible one can be measured in years.

The window to shape a federal med spa investigation is open during the investigation phase — before a target letter, before an indictment, before the charging decision is made. That window closes fast.

Why the Timing Is the Whole Game

Federal med spa enforcement is accelerating, and the inputs that feed it — state board discipline, FDA supply-chain data, and payer audits — are all increasing at once. A clinic that has received a board complaint, a payer audit, or an FDA inquiry should treat it as the possible front end of a federal matter, not an isolated event.

The time to bring in a white collar defense attorney is when the first sign appears, not after the indictment. Charging decisions are fluid early and fixed late. The earlier the involvement, the more options remain on the table.

Common Questions

Facing a Federal Med Spa or Health Care Investigation in Florida?

Pre-indictment defense work shapes what facts the government and the probation officer ever rely on. In federal health care cases, that window opens early and closes fast.

AMC Defense Law represents physicians, APRNs, PAs, and clinic owners in federal investigations and prosecutions involving health care fraud, the Anti-Kickback Statute, and unapproved-drug enforcement — in Florida and nationwide. If you have received a subpoena, a target letter, or a board complaint that could lead to a federal matter, contact us for a confidential consultation.